Advancing International R&D, Effective Sample Management and Global Biobanking Harmonisation

Pharma IQ’s 3rd Annual Global Biobanking 2010 conference will be held in London on the 28th-29th September 2010.

With the multitude of practical, ethical and regulatory considerations that must be taken into account by anyone setting-up or running a biobank mean that it is often difficult to keep abreast of the latest developments in the field.

This conference is a high-level forum that brings together key people from research, academia and industry to discuss the most significant challenges and technological developments in the field, as well as network with your peers.

Pharma IQ’s annual Biobanking conference has been rated by your peers as the top event for quality of information presented, as well as for the valuable and detailed dialogue during the many networking opportunities with top biobankers from industry and research alike. Now in it’s 3rd Year Biobanking has welcomed over 200 Attendees from over 140 different organisations

With representation from a wide range of major pharmaceutical companies and keynote presentations from internationally-recognised thought leaders in biobanking, this promises to be an event not-to-be-missed!

Confirmed Speakers Include:

  • Laurie Overton
    Manager of Biobank
    GlaxoSmithKline
  • Andreas Koehler
    Global Head Clinical Pharmacogenetics
    Boehringer-Ingelheim
  • Arndt Schmitz
    Research Biobank
    Bayer-Schering
  • Bas de Jong
    Manager
    Erasmus MC Tissue Bank
  • Björn Dahllöf
    Global Biobank Head
    AstraZeneca
  • Amelia Wall Warner
    Head of Clinical Pharmacogenomics and Clinical Specimen Management
    Merck & Co

Including 7 new industry case studies!

AstraZeneca, GlaxoSmithKline, Eli Lilly, Merck, Bayer-Schering, Novartis and Boehringer-Ingelheim

Hot topics for 2010 will include:

  • Developing an efficient global biobank network
  • Ensuring consistent, high standards of quality control
  • Efficient data handling and database management
  • Sample tracking and delivery
  • New methods for securing additional funding
  • Smart storage techniques and technologies
  • The viability of automation in specific situations

This year’s event will also feature an exclusive pre-conference interactive workshop session with AstraZeneca’s Global Biobank Head, Björn Dahllöf, who will be guiding attendees through the basic concepts and uses of a global biobank network aimed at identifying biospecimens for research.

Why Pharma IQ's Biobanking event is different to others:

  • A truly global / UN focus; giving participants a country by country examination of biobanking practices, legalities, ethics and standards
  • Brings together more industry speakers than ever before: 7 brand new industry case studies (AstraZeneca, Merck, GlaxoSmithKline, Boehringer-Ingelheim, Bayer-Schering, Novartis & Eli Lilly
  • It delivers practical information and 'take home' value so you can justify attendance; including a choice of 4 pre-conference interactive workshops on setting up and developing your biobank network, from IP to IT
  • Provides Continuing Professional Education (CPD) points for your time spent advancing your knowledge - Tailored matchmaking onsite to ensure you meet the people you want
Sponsors Media Partners
_spex _media

[ Register Now ]